Autophagy-mediated chemosensitization by cysteamine in cancer cells

International Journal of Cancer

Volumn 129, Issue 5, 2011, Pages 1087-1095

  Wan, Xiao Mei ^a   Zheng, Fang ^a   Zhang, Li ^a   Miao, Yan Yan ^a   Man, Na ^a   Wen, Long Ping ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

autophagy; chemosensitization; chemotherapy; cysteamine; doxorubicin

Indexed keywords

BAFILOMYCIN A1; DOXORUBICIN; MERCAPTAMINE; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AUTOPHAGY; CYSTEAMINE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; HELA CELLS; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; TUMOR CELLS, CULTURED;

EID: 79959693246     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25771     Document Type: Article

References (29)

1. Piulachs MD, Belles X,. Stimulatory activity of cysteamine on juvenile-hormone release in adult females of the cockroach, Blattella-Germanica. Comp Biochem Physiol A Comp Physiol 1989; 94: 795-8. (Pubitemid 20028247)
2. Szabo S, Reichlin S,. Somatostatin in rat tissues is depleted by cysteamine administration. Endocrinology 1981; 109: 2255-7. (Pubitemid 12252359)
3. McIntosh CH, Bakich V, Bokenfohr K, DiScala-Guenot D, Kwok YN, Brown JC,. Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity. Regul Pept 1988; 21: 205-18.
4. Tsuzuki Y, Matsubara M, Ashizawa K,. Effect of cysteamine added to maturation medium on nuclear maturation, glutathione and ATP contents of pig oocytes. J Mamm Ova Res 2009; 26: 139-44.
5. Anand T, Kumar D, Chauhan MS, Manik RS, Palta P,. Cysteamine supplementation of in vitro maturation medium, in vitro culture medium or both media promotes in vitro development of buffalo (Bubalus bubalis) embryos. Reprod Fertil Dev 2008; 20: 253-7. (Pubitemid 351156610)
6. Liber HL, Benforado K, Little B,. The molecular nature of mutants induced by X Rays is altered by the presence of the radioprotector cysteamine. Radiat Res 1989; 118: 324-9. (Pubitemid 19139629)
7. Harris JW, Phillis TL,. Radiobiological and biochemical studies of thiophosphate radioprotective compounds related to cysteamin. Radiat Res 1971; 46: 363-79.
8. Buchan B, Kay G, Matthews K, Cairns D,. Formulation and evaluation of cysteamine for ophthalmic delivery. J Pharm Pharmacol 2009; 61: A73-4.
9. Gahl WA,. Early oral cysteamine therapy for nephropathic cystinosis. Eur J Pediatr 2003; 162 (Suppl 1): S38-41. (Pubitemid 38064743)
10. Prescott LF, Sutherland GR, Park J, Smith IJ, Proudfoot AT,. Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet 1976; 2: 109-13.
11. Jin SK, White E,. Tumor suppression by autophagy through the management of metabolic stress. Autophagy 2008; 4: 563-6.
12. Kondo Y, Kanzawa T, Sawaya R, Kondo S,. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5: 726-34. (Pubitemid 41486365)
13. Levine B,. Cell biology: autophagy and cancer. Nature 2007; 446: 745-7. (Pubitemid 46582063)
14. Ding WX, Ni HM, Gao W, Hou YF, Melan MA, Chen X, Stolz DB, Shao ZM, Yin XM,. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem 2007; 282: 4702-10. (Pubitemid 47101001)
15. Wang YJ, Singh R, Massey AC, Kane SS, Kaushik S, Grant T, Xiang YQ, Cuervo AM, Czaja MJ,. Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus. J Biol Chem 2008; 283: 4766-77.
16. Levine B, Yuan J,. Autophagy in cell death: an innocent convict? J Clin Invest 2005; 115: 2679-88. (Pubitemid 41434392)
17. Hoyer-Hansen M, Jaattela M,. Autophagy-an emerging target for cancer therapy. Autophagy 2008; 4: 574-80.
18. Levine B,. Unraveling the role of autophagy in cancer. Autophagy 2006; 2: 65-6.
19. Carew JS, Nawrocki ST, Cleveland JL,. Modulating autophagy for therapeutic benefit. Autophagy 2007; 3: 464-7. (Pubitemid 47293728)
20. Shingu T, Fujiwara K, Bogler O, Akiyama Y, Moritake K, Shinojima N, Tamada Y, Yokoyama T, Kondo S,. Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity. Autophagy 2009; 5: 537-9.
21. Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, Cleveland JL,. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007; 110: 313-22. (Pubitemid 47026849)
22. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB,. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117: 326-36. (Pubitemid 46203961)
23. Lefranc F, Facchini V, Kiss R,. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 2007; 12: 1395-403.
24. Brawer JR, Reichard G, Small L, Schipper HM,. The origin and composition of peroxidase-positive granules in cysteamine-treated astrocytes in culture. Brain Res 1994; 633: 9-20. (Pubitemid 24021238)
25. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T,. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19: 5720-8.
26. Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC,. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 2007; 282: 5641-52. (Pubitemid 47093730)
27. Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, Webster JA, Lewis TA, O'Kane CJ, Schreiber SL, Rubinsztein DC,. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007; 3: 331-8. (Pubitemid 46789270)
28. Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P, O'Kane CJ, Floto RA, et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol 2008; 4: 295-305. (Pubitemid 351550888)
29. Mizushima N, Yoshimori T,. How to interpret LC3 immunoblotting. Autophagy 2007; 3: 542-5. (Pubitemid 350060049)